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Abstract
Purpose There has been relatively little information about the treatment for ischiofemoral impingement (IFI) because of its 
rarity as well as the uncertainty of diagnosis. The aim of this study was to provide the reader with the available treatment 
strategies and their related outcomes for IFI based on the best available evidence, whilst highlighting classically accepted 
ways of treatment as well as relatively new surgical and non-surgical techniques.
Methods A systematic review of the literature from Medline, Embase, AMED, Cochrane and Google Scholar was undertaken 
since inception to December 2017 following the PRISMA guidelines. Clinical outcome studies, prospective/retrospective 
case series and case reports that described the treatment outcome for IFI were included. Animal or cadaveric studies, trial 
protocols, diagnostic studies without any description of treatments, technical notes without any results, and review articles 
were excluded.
Results This systematic review found 17 relevant papers. No comparative studies were included in the final records for quali-
tative assessment, which means all the studies were case series and case reports. Eight studies (47.1%) utilised non-surgical 
treatment including injection and prolotherapy, followed by endoscopic surgery (5 studies, 29.4%) then open surgery (4 
studies, 23.5%). Mean age of the participants was 41 years (11–72 years). The mean follow-up was 8.4 months distributed 
from 2 weeks to 2.3 years. No complications or adverse effects were found from the systematic review.
Conclusion Several treatment strategies have been reported for IFI, and most of them have good short- to medium-term 
outcomes with a low rate of complications. However, there are no comparative studies to assess the superiority of one tech-
nique over another, thus further research with randomised controlled trials is required in this arena. This study explores the 
wide variety and categories of different treatments used for IFI to guide physicians and shed light on what can be done for 
this challenging cohort of patients.
Level of evidence III.
Keywords Ischiofemoral impingement · Quadratus femoris · Endoscopy · Extra-articular impingement · Systematic 
review · Hip
Introduction
Ischiofemoral impingement (IFI) is an uncommon cause of 
pain and snapping in the hip, buttock, and groin. The pathol-
ogy occurs because of a reduction of space between the 
lesser trochanter (LT) and the lateral border of the ischium, 
which leads to entrapment of the quadratus femoris (QF) 
muscle [37]. IFI was first described by Johnson in 1977 in 
three patients who had undergone an osteotomy of the hip or 
a hip replacement previously [18]. However, despite it being 
described almost 40 years ago, it is still frequently misdi-
agnosed or neglected because of its rarity, and the absence 
of specific clinical findings and diagnostic tests [14, 26]. 
Recently, several studies on the radiological features of IFI 
and distance between the ischium and the LT, i.e. ischiofem-
oral distance‚ have been published [14, 20, 31]. We have 
also recently reported on the normal ischiofemoral distance 
(measured as the smallest distance between the lateral cortex 
of ischial tuberosity and the medial cortex of the LT) and its 
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variations using the computed tomography (CT) data of 298 
normal hips and found that the mean ischiofemoral distance 
was 18.6 mm in females and 23 mm in males and that it 
increased by 1.06 mm for each 1 mm of offset and dropped 
by 0.09 mm with each year of age [14]. In addition, it was 
reported that narrowed ischiofemoral distance was associ-
ated with abnormal magnetic resonance imaging (MRI) sig-
nal intensity in the QF muscle [20, 31]. Furthermore, some 
studies report that the QF muscle signal changes on MRI 
or symptoms of IFI could be observed in patients without 
ischiofemoral distance narrowing (e.g. due to tumour [30] or 
exostosis [35, 38]), keeping the pathogenesis of IFI uncer-
tain [20, 28].
There is relatively little information available on the best 
management strategy for patients with IFI. This is mainly 
because of the uncertainty of diagnosis and the fact that 
conservative treatment such as physiotherapy or activity 
modification is undertaken as a first step in the manage-
ment of most cases with IFI [2, 26]. Surgical treatment is 
reserved for patients in whom conservative treatment fails. 
Until recently, excision of the LT with an open approach had 
been recommended as a normal operative technique for IFI 
with a narrowed ischiofemoral distance [2], however, with 
the improvement in arthroscopic techniques and devices, 
some authors report on the entire LT being accessed and 
resected endoscopically [10, 19, 40].
Currently, there is a lack of evidence in the literature that 
provides hip surgeons with evidence-based recommenda-
tions on the management of IFI, and no systematic review 
has been published in this arena thus far. The aim of this 
study, therefore, was to provide the reader with the available 
treatment strategies and their related outcomes for IFI based 
on the best available evidence, whilst highlighting classically 
accepted ways of treatment as well as relatively new surgical 
and non-surgical techniques. The objective of this systematic 
review would be to look at patients from both genders with 
no demographic restriction, who had any treatment for IFI 
to treat and alleviate buttock and posterior hip pain with or 
without distal neuropathic pain radiation and by including 
the studies reporting on IFI treatment and this would provide 
the current treatment strategies in practice.
Materials and methods
Search strategy
The PICOS tool was adopted to formulate the research 
question and modified since no comparators were sought 
in this study [24]. The study included randomised trials, 
cohort studies, case controls, and case studies as the study 
designs of interest. The protocol of this systematic review 
was developed and has been registered in the International 
Prospective Register of Systematic Reviews (PROSPERO 
2017 CRD42017084855) [17].
Two reviewers searched the online databases (Medline, 
Embase, AMED, Cochrane, and Google Scholar) for the 
literature describing the outcomes of treatments for IFI. 
The Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines were used for design-
ing this study [25]. Database search was conducted on 31st, 
December 2017 and retrieved articles from the databases 
since inception to the search date. The electronic search cita-
tion algorithm used was: [ischiofemoral (Title/Abstract) OR 
ischiofemoral (Title/Abstract)]. The search also included the 
yet to be printed search results and grey literature. Results 
were pooled and exported to Mendeley reference manager 
software (Elsevier, Amsterdam, The Netherlands) and dupli-
cates were removed electronically and manually. The two 
reviewers independently reviewed all the titles and abstracts. 
The remaining search results were divided equally between 
the two reviewers and reviewed in duplicate applying the 
inclusion and exclusion criteria. Any discrepancies at the 
title and abstract stage as well as the full-text stage were 
resolved by consensus between the two reviewers and the 
third more senior author. This process led to 100% agree-
ment between the authors.
Study selection (inclusion and exclusion criteria)
Levels 1, 2, 3, 4, and 5 evidence (according to the Oxford 
Centre for Evidence-Based Medicine [29]) English language 
studies were eligible for inclusion in the systematic review. 
We excluded duplicate subject publications within separate 
unique studies. Both electronically published articles and 
print journals were included for this review. Clinical out-
come studies, prospective case series, retrospective case 
series and case reports that described the outcomes of treat-
ments for IFI were included. Procedures regardless of open 
surgery, endoscopic surgery or non-surgical treatment were 
included. Studies on animal models and basic science stud-
ies (e.g. cadaveric studies) were excluded. Studies describing 
trial protocols without any results, diagnostic studies without 
any description of treatments, technical notes without any 
results, and review articles were also excluded. The detailed 
inclusion and exclusion criteria are shown in Table 1.
Data extraction and analysis
Both the reviewers independently extracted the relevant 
study data from the final pool of included articles and 
recorded this data on a spreadsheet designed a priori in 
Microsoft Excel 2013 (Microsoft Corporation, Redmond, 
Washington, USA). Participant-specific demographics 
extracted from each study included the number of cases, 
gender distribution, mean age with range (years), mean 
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length of follow-up, physical, clinical or radiological con-
dition before the treatment, treatment strategy used in the 
study, final outcome, and specific comments (if any). Study-
specific demographics extracted from each study included 
the level of evidence according to the simplified evidence 
level table from the Centre for Evidence-Based Medicine, 
Oxford, country where the study was conducted and the 
year of publication. Studies were then analysed and assessed 
using the Joanna Briggs Institute Critical Appraisal Check-
list (JBICAC) for case reports and case series [17]. A scor-
ing system was implemented based on the findings from the 
studies. JBICAC scores the answers to its questions as yes, 
no, unclear or not applicable. We then allocated numbers 
to each answer where domains answering with yes gets 2 
points, unclear gets 1 and no gets 0. A scoring of 16 and 
20 indicated the maximum points of case report and case 
series, respectively.
Statistical analyses
The extracted data were then analysed using Microsoft Excel 
2013. Statistical analyses in this study focused on descriptive 
statistics by calculating the mean values for ages and follow-
up times providing an overview summary statistic of ages 
and follow-up times.
Results
The initial search found a total of 381 studies from all 
the databases. The search process led to 100% agreement 
among three authors. Duplicates found were 165 articles 
and were removed. A total of 216 articles were then identi-
fied for title screening. One hundred and thirty-four arti-
cles were excluded based on the inclusion criteria leaving 
82 articles for abstract screening. Fifty-seven articles were 
then excluded and 25 were included for full-text review. 
Eventually, 17 studies met all the inclusion criteria and 
were eligible for critical appraisal, quality assessment 
and included in the study. Of the participants, 15 (35.7%) 
were males and 27 (64.3%) were females (data availability: 
100%). Mean age of the participants was 41 years (range 
11–72 years). The mean follow-up period was 8.4 months 
distributed from 2 weeks to 2.3 years after the treatment. 
Study demographics are shown in Table 2. No complica-
tion or adverse event was found from the systematic review. 
The flow chart of the literature search algorithm is shown 
in Fig. 1. The oldest study included in this review was pub-
lished in 2011. All the studies included in this systematic 
review were level 4 studies, which means there were no com-
parative studies found. Due to lack of homogeneity in stud-
ies, a meta-analysis was deemed unsuitable for this study.
Three major treatment strategies were found from this 
systematic review. Eight studies (47.1%) utilised non-sur-
gical treatment including injection and prolotherapy, fol-
lowed by endoscopic surgery (five studies, 29.4%) and then 
open surgery (four studies, 23.5%). Data extracted from all 
the studies are shown in Table 3. The outcomes of quality 
assessment using JBICAC are shown in Tables 4 and 5.
Non‑surgical treatment (eight studies)
The overall quality of the eight articles was 80% based on 
the JBICAC ranging from 68.75 to 100% [3, 11, 21–23, 37, 
39, 41]. Four articles reported using conservative treatment 
(e.g. activity restriction, intake of non-steroidal anti-inflam-
matory drugs (NSAIDs) or physiotherapy) [11, 23, 37, 41]. 
Three articles reported the outcome following ultrasound 
(US) guided injection [21, 22, 39]. One article mentioned 
deploying prolotherapy with polydeoxyribonucleotide 
Table 1  Inclusion and exclusion criteria applied to articles identified 
in the literature
Inclusion criteria
1. All levels of evidence
2. Written in the English language
3. Studies on humans
4. Studies reporting the outcome of treatment for ischiofemoral 
impingement
Exclusion criteria
1. Studies describing trial protocols without any results
2. Animal studies
3. Basic science studies (e.g. cadaveric studies)
4. Diagnostic studies without any description of treatments
5. Technical notes without any results
6. Reviews, systematic reviews
Table 2  Demographics of the study
Parameter
Studies analysed 17 studies
Levels of evidence: 4 17 studies (100%)
  Case series 3 studies (17.6%)
  Case report 14 studies (82.4%)
Participants (cases)
 Male 15 (35.7%)
 Female 27 (64.3%)
Mean follow-up time (range) 8.4 months 
(2 weeks–
2.3 years)
Mean participant age (range) 41.0 (11–72) years
Approach of treatment
 Non-surgical treatment 8 studies (47.1%)
 Open surgery 4 studies (23.5%)
Endoscopic surgery 5 studies (29.4%)
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sodium mixed with the local anaesthetics under fluoroscopic 
and US guidance [3].
Open surgical treatment (four studies)
The overall quality of studies was 78.1% based on the JBI-
CAC ranging from 62.5 to 100%. The four open surgical 
treatment articles were subdivided based on the treatment 
modality [2, 30, 35, 38]. Two articles reported open sur-
gical resection of the exostosis [35, 38]. One case report 
mentioned performing an open surgical resection of the LT 
[2]. One case report described open surgical resection of 
a lipomatous tumour in lateral position using a posterior 
incision [30].
Endoscopic surgical treatment (five studies)
The overall quality of studies was 91.5% based on the JBI-
CAC ranging from 81.25 to 100%. All of the five articles 
were endoscopic surgical resection of the LT in supine posi-
tion [10, 12, 19, 33, 40]. Two articles reported on perform-
ing a partial resection of the LT [10, 33] and three articles 
reported on entire resection of LT [12, 19, 40].
Discussion
The most important findings in this study are the availabil-
ity of three main treatment strategies for IFI being used in 
current clinical practice. This study reviews all the cases of 
treatment for IFI (42 cases) with their results reported in 
the English literature and describes the outcomes of several 
techniques, which are divided into three categories: non-
surgical treatment, open surgical treatment, and endoscopic 
surgical treatment. The basic pathology of IFI is that ischi-
ofemoral space is reduced and this leads to compression 
of the QF muscle within the space causing pain. The QF 
muscle originates from the external border of the ischial 
tuberosity and inserts into the upper part of the linea quad-
rata of the proximal femur and is at risk of compression 
when the ischiofemoral space is reduced. The aetiology 
for IFI, i.e. the reason for narrowing of the ischiofemoral 
space, is variable, which includes ageing (muscle atrophy), 
female gender (increased width of pelvis), coxa profunda, 
coxa valga, valgus hip due to proximal femoral osteotomy, 
Legg–Calve–Perthes disease, total hip replacement with 
reduced femoral offset or medialized socket, peritrochanteric 
fractures with involvement of LT, abductor muscle injury 
causing uncompensated hip adduction during gait, and mul-
tiple or isolated exostoses [26]. The treatment in patients 
with IFI usually starts with conservative approaches such as 
rest, modification of activities and anti-inflammatory drugs 
Fig. 1  PRISMA flowchart for 
results of the literature database 
search
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ten
do
n i
ns
er-
tio
n s
ite
 w
ith
 
th
e m
ain
 ai
m
 
be
in
g p
ain
 
re
lie
f. 
Cu
rre
nt
 
hy
po
th
es
es
 
su
gg
es
t t
ha
t 
th
e p
re
se
nc
e 
of
 a 
lo
ca
l 
irr
ita
nt
 m
ay
 
att
ra
ct 
in
fla
m
-
m
ato
ry
 m
ed
ia-
to
rs 
an
d p
os
-
sib
ly
 st
im
ul
ate
 
th
e r
ele
as
e 
of
 g
ro
wt
h 
fac
to
r o
r a
ct 
as
 a 
va
sc
ul
ar
 
sc
ler
os
an
t
 H
ay
at 
et 
al.
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14
UK
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1
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1 y
ea
r
16
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Th
e p
ati
en
t h
ad
 an
 18
-m
on
th
 
hi
sto
ry
 of
 a 
du
ll,
 de
ep
 ac
he
 in
 
hi
s l
ef
t g
ro
in
, e
xa
ce
rb
ate
d b
y 
ex
er
cis
e, 
fo
llo
wi
ng
 an
 in
ju
ry
 
pl
ay
in
g f
oo
tb
all
. A
 pl
ain
 
ra
di
og
ra
ph
 re
ve
ale
d a
 ch
ro
ni
c 
ap
op
hy
se
al 
av
ul
sio
n f
ra
ctu
re
 
of
 th
e i
sc
hi
um
 w
ith
 ex
ce
ss
ive
 
ca
llu
s f
or
m
ati
on
. C
T 
sc
an
 an
d 
M
RI
 re
ve
ale
d t
ha
t t
he
 bo
ny
 
pr
ot
ub
er
an
ce
 w
as
 re
sp
on
sib
le 
fo
r s
ym
pt
om
ati
c I
FI
No
n-
op
er
ati
ve
 m
an
ag
e-
m
en
t w
as
 un
de
rta
ke
n 
wi
th
 pa
in
ki
lle
rs 
as
 
ne
ed
ed
, r
es
t, 
ac
tiv
ity
 
m
od
ifi
ca
tio
n a
nd
 
ph
ys
io
th
er
ap
y e
xe
r-
cis
e r
eg
im
e
Ov
er
 th
e 1
2 m
on
th
s 
af
ter
 tr
ea
tm
en
t, 
th
e 
pa
tie
nt’
s s
ym
pt
om
s 
se
ttl
ed
 an
d h
e 
re
po
rte
d o
nl
y a
 m
ild
, 
in
fre
qu
en
t a
ch
e i
n 
th
e g
ro
in
 in
 th
e fi
na
l 
fo
llo
w-
up
. H
e h
as
 
re
su
m
ed
 no
rm
al 
sp
or
tin
g a
cti
vi
tie
s 
wi
th
ou
t d
isc
om
fo
rt
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[2
4]
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13
So
ut
h K
or
ea
4
0
1
1
6 w
ee
ks
48
48
Hi
p M
RI
 re
ve
ale
d t
he
 in
cr
ea
se
d 
sig
na
l i
nt
en
sit
y o
f Q
F 
wi
th
 
co
nc
ur
re
nt
 na
rro
wi
ng
 of
 th
e 
isc
hi
of
em
or
al 
sp
ac
e. 
On
 ax
ial
 
T2
-w
eig
ht
ed
 fa
t-s
up
pr
es
se
d 
M
RI
, t
he
re
 w
er
e d
iff
us
e 
oe
de
m
a a
nd
 in
cr
ea
se
d s
ig
na
l 
in
ten
sit
y w
ith
in
 Q
F.
 In
iti
al 
VA
S 
wa
s 7
–8
/1
0
NS
AI
Ds
 an
d g
ab
ap
en
-
tin
 w
er
e p
re
sc
rib
ed
 
fo
r p
ain
 re
lie
f. 
Ho
t 
pa
ck
, u
ltr
as
ou
nd
, 
an
d i
nt
er
fer
en
tia
l 
cu
rre
nt
 th
er
ap
ies
 
we
re
 ap
pl
ied
 ar
ou
nd
 
th
e h
ip
 ar
ea
. T
he
 
pa
tie
nt
 re
ce
ive
d a
n 
ex
er
cis
e p
ro
gr
am
 fo
r 
str
etc
hi
ng
 of
 th
e h
ip
 
m
us
cle
 an
d c
on
ne
c-
tiv
e t
iss
ue
s
Af
ter
 6 
we
ek
s o
f t
re
at-
m
en
t, 
th
e p
ain
 w
as
 
de
cr
ea
se
d g
ra
du
all
y 
to
 2–
3/
10
 in
 V
AS
 Y
an
ag
ish
ita
 
et 
al.
 [4
1]
20
12
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il
4
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1
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th
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31
31
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di
og
ra
ph
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ex
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in
ati
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de
m
on
str
ate
d a
 va
lg
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 fe
m
or
al 
ne
ck
, i
sc
hi
of
em
or
al 
sp
ac
e 
na
rro
wi
ng
, a
nd
 th
e p
re
se
nc
e 
of
 cy
sts
 in
 th
e i
sc
hi
um
. M
RI
 
sh
ow
ed
 in
cr
ea
se
d s
ig
na
l i
n Q
F 
on
 T
2-
we
ig
ht
ed
 se
qu
en
ce
s
No
n-
su
rg
ica
l t
re
atm
en
t 
in
clu
di
ng
 a 
tak
in
g 
NS
AI
Ds
 fo
r 7
 da
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an
d d
ail
y p
hy
sic
al 
th
er
ap
y f
or
 st
re
tch
in
g 
an
d s
tre
ng
th
en
in
g t
he
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ic 
m
us
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Af
ter
 3 
m
on
th
s o
f 
tre
atm
en
t, 
th
e p
ati
en
t 
sh
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ed
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ca
nt
 
fu
nc
tio
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l i
m
pr
ov
e-
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en
t a
nd
 re
su
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ou
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 re
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. 
[3
8]
20
12
Tu
rk
ey
4
0
1
1
NA
11
11
Th
e p
ati
en
t c
om
pl
ain
ed
 of
 hi
p 
an
d g
ro
in
 pa
in
, w
hi
ch
 g
ra
du
-
all
y i
nc
re
as
ed
 du
rin
g t
he
 la
st 
2 m
on
th
s. 
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e i
sc
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ra
l s
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 m
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pr
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in
en
t i
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eig
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 se
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en
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m
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 oe
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m
a i
n Q
F 
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 th
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fat
-su
pp
re
ss
ed
 T
2-
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ig
ht
ed
 
se
qu
en
ce
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ns
er
va
tiv
e m
eth
od
s 
in
clu
di
ng
 re
st,
 ac
tiv
-
ity
 re
str
ict
io
n, 
an
d 
tak
in
g N
SA
ID
s w
er
e 
co
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uc
ted
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e p
ati
en
t w
as
 su
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ce
ss
fu
lly
 tr
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ted
 
co
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er
va
tiv
ely
Op
en
 su
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ica
l t
re
atm
en
t
 P
ap
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tsi
 
et 
al.
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Th
e p
ati
en
t s
uff
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ed
 fr
om
 IF
I 
se
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nd
ar
y t
o a
n i
nt
er
m
us
cu
lar
 
lip
om
a (
2.7
 ×
 2.
6 ×
 0.
5 c
m
), 
wh
ich
 w
as
 re
ve
ale
d o
n M
RI
 
an
d c
on
fir
m
ed
 at
 su
rg
er
y. 
Sh
e d
es
cr
ib
ed
 th
e p
ain
 as
 a 
co
ns
tan
t a
ch
e s
co
rin
g 9
/1
0 o
n 
VA
S 
wi
th
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ca
sio
na
l s
ha
rp
 
sh
oo
tin
g p
ain
s t
rig
ge
re
d b
y 
pr
ol
on
ge
d s
itt
in
g a
nd
 w
alk
in
g
Th
e e
nt
ire
 li
po
m
ato
us
 
tu
m
ou
r w
as
 ex
cis
ed
 
by
 op
en
 su
rg
er
y i
n 
th
e l
ate
ra
l p
os
iti
on
 
us
in
g p
os
ter
io
r 
in
cis
io
n
Th
e p
ati
en
t’s
 sy
m
p-
to
m
s i
m
pr
ov
ed
 
m
ar
ke
dl
y (
VA
S:
 
0.5
/1
0)
. S
he
 w
as
 
ab
le 
to
 si
t w
ith
ou
t 
an
y d
isc
om
fo
rt 
an
d 
th
er
e w
as
 no
 si
gn
 of
 
on
go
in
g s
cia
tic
 ne
rv
e 
irr
ita
tio
n o
r I
FI
. T
he
 
pa
tie
nt
 re
tu
rn
ed
 to
 
fu
ll-
tim
e w
or
k a
nd
 
no
 lo
ng
er
 re
qu
ire
s 
an
y a
na
lg
es
ia
Hi
sto
lo
gy
 
co
nfi
rm
ed
 
th
e p
re
se
nc
e 
of
 a 
be
ni
gn
 
in
ter
m
us
cu
-
lar
lip
om
a o
f 
th
e q
ua
dr
atu
s 
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or
is 
m
us
cle
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t s
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l 
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rd
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di
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p r
ev
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m
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Th
e p
ati
en
t p
re
se
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ed
 w
ith
 
hi
p p
ain
 of
 2-
ye
ar
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ra
tio
n. 
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di
og
ra
ph
, C
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 an
d M
RI
 
sh
ow
ed
 co
xa
 va
lg
a a
nd
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lay
-
in
g o
f t
he
 in
ter
tro
ch
an
ter
ic 
re
gi
on
 an
d f
em
or
al 
ne
ck
 as
 
we
ll 
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 ex
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to
se
s o
f t
he
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ch
ial
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be
ro
sit
y. 
Ex
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se
s a
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or
al 
m
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ph
ys
ea
l w
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in
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su
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n a
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rro
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ng
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 th
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es
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en
 su
rg
ica
l r
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n o
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he
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 m
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th
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ug
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ap
pr
oa
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Si
x m
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th
s p
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pe
r-
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ve
ly,
 hi
p p
ain
 w
as
 
im
pr
ov
ed
, a
pp
ea
rin
g 
on
ly
 af
ter
 w
alk
in
g 
lo
ng
 di
sta
nc
es
Th
e p
ati
en
t h
ad
 
a p
as
t h
ist
or
y 
of
 su
rg
ica
l 
re
se
cti
on
s 
of
 ex
os
to
se
s 
fro
m
 th
e l
ef
t 
kn
ee
 at
 ag
e 
13
, r
ig
ht
 kn
ee
 
at 
ag
e 1
8, 
an
d 
rig
ht
 hu
m
er
us
 
at 
28
. A
t 
pa
th
ol
og
ica
l 
ex
am
in
ati
on
, a
 
ty
pi
ca
l b
en
ig
n 
ex
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to
sis
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as
 
fo
un
d
 A
li 
et 
al.
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t s
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fu
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ng
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-
tio
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ur
y t
o t
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p w
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le 
ac
cid
en
tal
ly
 pe
rfo
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in
g t
he
 
sp
lit
s. 
Se
ve
n m
on
th
s l
ate
r, 
sh
e n
ot
ice
d a
n a
ud
ib
le 
an
d 
pa
lp
ab
le 
clu
nk
 in
 he
r h
ip
 
up
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 w
alk
in
g. 
M
RI
 sh
ow
ed
 
se
lec
tiv
e n
ar
ro
wi
ng
 of
 th
e 
isc
hi
of
em
or
al 
sp
ac
e a
nd
 Q
F 
sp
ac
e. 
CT
-g
ui
de
d s
ter
oi
d a
nd
 
lo
ca
l a
na
es
th
eti
c i
nj
ec
tio
n 
ar
ou
nd
 Q
F 
pr
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id
ed
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lie
f o
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he
r p
ain
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t n
ot
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e c
lu
nk
in
g, 
fo
r 2
4 h
Op
en
 su
rg
ica
l r
es
ec
-
tio
n o
f t
he
 le
ss
er
 
tro
ch
an
ter
 w
as
 
pe
rfo
rm
ed
Th
e p
os
t-o
pe
ra
tiv
e 
ra
di
og
ra
ph
 sh
ow
ed
 
ad
eq
ua
te 
de
co
m
pr
es
-
sio
n o
f t
he
 is
ch
i-
of
em
or
al 
sp
ac
e. 
At
 4 
we
ek
s f
ol
lo
wi
ng
 th
e 
su
rg
er
y, 
th
e p
ain
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d 
di
m
in
ish
ed
 to
 a 
m
ild
 
di
sc
om
fo
rt 
an
d t
he
re
 
wa
s n
o c
lu
nk
in
g. 
At
 
10
 w
ee
ks
 fo
llo
wi
ng
 
su
rg
er
y, 
th
e p
ati
en
t 
wa
s a
sy
m
pt
om
ati
c
Be
fo
re
 th
e 
re
se
cti
on
 of
 
th
e l
es
se
r 
tro
ch
an
ter
, 
th
e p
ati
en
t 
ha
d i
lio
tib
ial
 
ba
nd
 Z
-p
las
ty
 
wh
ich
 ha
d 
no
 eff
ec
t o
n 
th
e p
ati
en
t’s
 
sy
m
pt
om
s
2780 Knee Surgery, Sports Traumatology, Arthroscopy (2020) 28:2772–2787
1 3
Ta
bl
e 
3 
 (c
on
tin
ue
d)
Re
fer
en
ce
s
Ye
ar
Co
un
try
LO
E
Nu
m
be
r o
f c
as
es
M
ea
n f
ol
lo
w-
up
 
pe
rio
d
Ag
e
Co
nd
iti
on
 be
fo
re
 th
e t
re
atm
en
t
Tr
ea
tm
en
t m
eth
od
Re
su
lt
Ot
he
rs
M
ale
Fe
m
ale
To
tal
M
ea
n
Ra
ng
e
En
do
sc
op
ic 
su
rg
ica
l t
re
atm
en
t
 W
ils
on
 et
 al
. 
[4
1]
20
16
US
A
4
1
6
7
12
 m
on
th
s
46
15
–6
6
Al
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 tr
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m
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e w
er
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m
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th
e p
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en
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o p
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I t
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a p
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e o
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nd
 
all
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ur
 pa
tie
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d l
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 T
wo
 of
 
th
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 w
er
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re
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-
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pe
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 re
ve
ale
d 
oe
de
m
a a
nd
 at
ro
ph
y i
n t
he
 Q
F 
ad
jac
en
t t
o t
he
 is
ch
iu
m
, b
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s d
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f l
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s m
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m
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such as NSAIDs. One study [33] mentioned that in their 
high-volume hip arthroscopy practice, only 5% of patients 
diagnosed with IFI required surgical intervention. The objec-
tive of this study was to discuss the outcomes of the current 
treatment strategies for IFI because little has been published 
on definitive treatment for this condition so far.
Non‑surgical treatment
Of the 17 studies found in the systematic review, five stud-
ies reported on conservative treatment [3, 11, 23, 37, 41]. 
The studies described the results of ‘standard’ conservative 
methods, e.g. the combination of rest, activity modification, 
taking NSAIDs and gabapentin, physiotherapy, hot packs, 
and ultrasound-guided injections. All the studies reported 
good short-term results (from 2 weeks to 1 year) without any 
complications. This seems to be similar to the management 
of other impingement syndromes wherein the first line of 
therapy is usually conservative, because of its less invasive 
approach and good patient outcomes [4]. Females also tend 
to have a higher incidence of IFI than males and this might 
be due to the anatomy of the female pelvis [18]. Females 
have a wider and a shallower pelvis with a more prominent 
LT than in males that could lead to IFI [36].
Ultrasound-guided QF muscle injection was reported to 
be clinically effective [21]. The anatomical location of the 
QF and its relation to the sciatic nerve could explain why 
this intervention could be useful. The sciatic nerve is closely 
located between the anterior surface of the gluteus maximus 
and the posterior surface of the QF and therefore any inflam-
mation or spasm of this muscle will lead to irritation of the 
sciatic nerve. Injection of steroid, in this case, would be 
effective in terms of relieving the pain [34]. Another study 
reported that one of the ways to treat buttock pain arising 
from the piriformis muscle was to inject steroids and local 
anaesthetic [13]. Another study [21] proposed that injection 
of QF muscle under ultrasound guidance would be an accu-
rate and safe procedure, as for a piriformis muscle injection, 
an ultrasound-guided injection was known to be more accu-
rate than a fluoroscopically guided injection in a cadaveric 
model [6] and the two techniques were reported to have no 
difference in clinical outcomes [8]. Under ultrasound guid-
ance, they injected 8 mL of 0.25% lidocaine into the QF 
muscle of 14 patients who had deep tenderness localised to a 
point halfway between the lateral prominence of the greater 
trochanter and the ischial tuberosity corresponding to the 
location of the QF muscle belly, and the mean pain score 
decreased by 49.3% in 2 weeks after the injection. They 
reported narrowing of the ischiofemoral space was not found 
in 3 of 14 patients, so their samples might include patients 
with other pathology, e.g. piriformis syndrome or myofascial 
pain syndrome.
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A study [22] reported the outcome of ultrasound-guided 
prolotherapy with polydeoxyribonucleotide sodium for 
patients with IFI. Prolotherapy refers to the injection of an 
irritant into a specific site with the main aim being pain 
relief, while the mechanism is not completely understood. 
The presence of a local irritant might attract inflammatory 
mediators and possibly stimulate the release of growth fac-
tors or act as a vascular sclerosant [1, 32]. After prolother-
apy, the visual analogue scale (VAS) pain score was found to 
be minimal (0–1/10), and follow-up MRI revealed a slightly 
decreased enhancement of the QF muscle compared with 
that before prolotherapy. They concluded that prolotherapy 
could be an efficacious treatment option for patients with 
IFI because the therapeutic effect of steroid injections has 
only been reported to last from 1 week to 1 month [2] while 
prolotherapy showed a long-term effect for > 6 months.
Injections with Botox have also been increasingly used 
due to its mechanism of action and improvement in patient 
outcomes. Botox chemodenervation acts by increasing the 
“space-to-content”, which may reduce muscle compression 
in impingement syndromes [7]. This mechanism of action 
was reported where Botox was used to treat chronic exer-
tion compartment syndrome where pain faded and function 
improved [16].
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Table 5  Summary of the quality of studies within each major treat-
ment strategy
Non-surgical treatment
 Kim et al. [22] 90
 Chen et al. [3] 100
 Volokjina et al. [40] 81.3
 Kim et al. [23] 87.5
 Hayat et al. [11] 75
 Lee et al. [24] 68.8
 Yanagishita et al. [41] 68.8
 Tosun [38] 68.8
 Mean 80
Open surgical treatment
 Papoutsi [31] 100
 Schatteman [36] 62.5
 Viala [39] 75
 Ali [2] 75
 Mean 78.1
Endoscopic surgical treatment
 Wilson [41] 95
 Jo [20] 81.3
 Hatem [10] 100
 Safran [34] 81.3
 Hernandez [12] 100
 Mean 91.5
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Open surgical treatment
Of the 17 studies found in the systematic review, four studies 
reported on open surgical treatment for IFI [2, 30, 35, 38]. 
Two of them reported on the excision of ischial exostosis 
[35, 38], one reported on excision of a lipomatous tumour 
[30], and another study described the resection of the LT 
[2]. The pathologic lesion was accessed by either an anterior 
approach or lateral approach using the trochanteric flip or 
through splitting of the iliotibial band.
Although no complications related to the open approach 
were reported, these invasive approaches can potentially 
endanger the neurovascular structures around the lesion, 
which can lead to potential delays in rehabilitation. The 
potential structures in danger are the medial and lateral fem-
oral circumflex arteries, which course on the upper border of 
the QF muscle [27]. A cadaveric dissection study described 
that the medial circumflex artery was located on an average 
of 18 mm from the LT [9]. A very careful and meticulous 
approach is therefore mandatory when approaching the 
superior and posterior portions of the LT to avoid subse-
quent avascular necrosis of the femoral head. Furthermore, 
the resection of the LT requires detachment of the iliopsoas 
tendon [33], which risks persistent weakness of hip flexion.
Endoscopic surgical treatment
Of the 17 studies in the systematic review, five studies 
reported on the use of endoscopic surgical management 
[10, 12, 19, 33, 40]. All of them reported on partial or 
entire resection of the LT and good short- to medium-term 
outcomes (from 4 months to 2.3 years) without any neuro-
logical or vascular complication. Although the endoscopic 
approach is useful for visualisation of the LT and ischiofem-
oral space, a concern that arises when using this technique 
is the increased risk of damaging the femoral circumflex 
artery as well as the perforating femoral artery which could 
explain why many arthroscopic surgeons have not embarked 
on utilising this approach [10]. Endoscopic surgery is con-
sidered as a minimally invasive surgical decompression 
technique with fewer complications compared with the open 
procedure. The psoas tendon has shown some potential for 
regeneration after its release following endoscopic surgery 
[15]. Although endoscopic surgery is performed to treat IFI 
caused by narrowing of the IFI space, it could also help to 
debride the compromised QF muscle [20].
Due to the location of the LT, the arthroscopic procedure 
can be approached either anteriorly or posteriorly. A study 
[10] described the posterior approach and reported favour-
able outcomes without any complications. However, at the 
level of the LT, the sciatic nerve is located about 4 mm from 
the femoral border [5], thus it can be in danger of injury 
unless it is approached very carefully. Another study [19] 
mentioned that the anterior approach was better than poste-
rior approach because the anterior approach can avoid the 
need to divide the QF muscle and it minimises the risk of 
damage to the sciatic nerve as well as circumflex femoral 
vessels.
Partial resection of the LT allowed widening of the ischi-
ofemoral space without releasing all of the iliopsoas tendon 
insertions, as well as a potentially decreased risk of stress 
fracture in comparison with complete resection [10]. This 
fact may be of particular important to high-performance ath-
letes with IFI. A study [33], that reported the entire resection 
of the LT, partly admitted this risk by mentioning “with this 
patient accepting the almost assured risk of persistent hip 
flexor weakness”. However, another study [40] insisted that 
the entire LT should be removed to prevent persistence of 
the LT impingement due to inadequate resection of bone, 
which might occur with a partial resection since a thorough 
dynamic post-resection assessment for impingement cannot 
be completed with the patient in the supine position on the 
operating table.
The endoscopic approach seems to have many advantages 
when compared with the open approach especially in terms 
of the extent of soft tissue damage. However, care should be 
taken to remove as much bony debris as possible to reduce 
the risk of heterotopic ossification [33].
The strengths of this systematic review include the pur-
suit of knowledge in an important arena that has scarce pub-
lished information and remains a topical subject for sports 
physicians and surgeons alike. The methodology is sound 
and encompasses a broad-based and comprehensive sys-
tematic literature search of multiple databases with multiple 
reviewers allowed for a very inclusive approach to capturing 
the vast majority of the existing literature. In addition, the 
included studies were critically appraised using a validated 
quality measurement tool [17].
Nonetheless, there are limitations which include the 
inclusion of English only studies and the overall low level 
of evidence available in the included studies on this topic 
(level 4 studies only). Non-prospective designs are prone 
to data inaccuracy as well as missing information, which 
subjects them to selection and source bias. Publication bias 
should also be recognised, and these may diminish the accu-
racy of the data collected and therefore limits the quality of 
a systematic review without a doubt.
While this current level of evidence reflects the novel and 
emerging nature of the treatment strategies for IFI, future 
studies should address comparative effectiveness of the 
various treatment options in this arena. Most of the studies 
lacked quantitative metrics in their analysis and hence quan-
titative conclusions could not be drawn on recommending 
one treatment strategy over another. To make any specific 
recommendations for orthopaedic surgeons with regards 
to treatment decisions, adequately powered long-term 
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comparative studies focusing on two or three specific meth-
ods of treatment need to be conducted in the future.
Conclusion
Although there are several different treatment techniques 
reported, the current best evidence does not support any one 
treatment technique as a superior method for treating IFI. 
There, unfortunately, remains a paucity of comparative stud-
ies, which makes it difficult to perform a meaningful assess-
ment of the outcome of each procedure. Of the 17 studies 
found in the systematic review, conservative treatment as 
well as open/endoscopic surgical resection of the LT, were 
well-reported, though they were only described in limited 
case series and case reports.
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